Kodiak Sciences (KOD) Change in Accured Expenses (2017 - 2026)
Kodiak Sciences (KOD) reported Change in Accured Expenses of $4.6 million for Q1 2026, up 93.55% on a YoY basis from $2.4 million in Q1 2025, and up 228000.0% quarter-over-quarter from -$2000.0 in Q4 2025.
Kodiak Sciences (KOD) Change in Accured Expenses (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Change in Accured Expenses for 10 years, with the latest figure at $4.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 93.55% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $11.5 million (up 1913.33% YoY), and the FY2025 full-year result was $9.3 million, up 225.8% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $4.6 million, up from -$2000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $13.7 million in Q1 2022, with the low at -$12.2 million in Q2 2022.
- Historically, Change in Accured Expenses has averaged -$511352.9 across 5 years, with a median of $408000.0 in 2024.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses plunged 403.28% — and 2025, when it soared 398.59%.
- Kodiak Sciences' Change in Accured Expenses stood at -$7.6 million in 2022, then jumped by 39.27% to -$4.6 million in 2023, then jumped by 108.79% to $408000.0 in 2024, then tumbled by 100.49% to -$2000.0 in 2025, then jumped by 228000.0% to $4.6 million in 2026.
- The last three Change in Accured Expenses figures came in at $4.6 million (Q1 2026), -$2000.0 (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 4.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.56 Mn |
| Mar 31, 2026 | 4.56 Mn |
| Dec 31, 2025 | -2,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | 5.64 Mn |
| Sep 30, 2025 | 5.64 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 408,000.00 |
| Dec 31, 2024 | 408,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | -3.32 Mn |
| Mar 31, 2024 | -5.59 Mn |
| Mar 31, 2024 | -5.59 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Dec 31, 2023 | -4.64 Mn |